Interim report 1 January - 30 September 2010
(Thomson Reuters ONE) -
Interim period, 1 January - 30 September 2010
Net sales amounted to SEK 173.3 million (151.2), an increase of SEK 22.1 million
(15%). Excluding foreign exchange effects, the increase in net sales was 25%1).
Operating profit was SEK 40.1 million (36.4), an improvement of SEK 3.7 million
(10%). Excluding foreign exchange effects, operating profit rose by 39%1).
Profit before tax was SEK 51.1 million (42.6), an increase of SEK 8.5 million
(20%).
Profit after tax was SEK 34.3 million (29.3), an improvement of SEK 5.0 million
(17%).
Earnings per share amounted to SEK 1.99 (1.70).
The period's cash flow from operating activities before changes in working
capital was SEK 41.9 million (40.0). Total cash flow for the period was SEK
25.7 million (29.7). Dividends of SEK 25.8 million (6.9) were paid during the
period at the same time that the company raised SEK 4.9 (0,0) million from the
new shares issued in connection with the redemption of warrants. Cash and cash
equivalents at 30 September 2010 amounted to SEK 125.7 million (87.5).
Third quarter 1 July - 30 September 2010
Net sales amounted to SEK 48.9 million (38.7), an increase of SEK 10.2 million
(26%). Excluding foreign exchange effects and the effect of early deliveries in
the second quarter 2009, the increase in net sales was 20%1) 2).
Operating profit was SEK 8.6 million (6.4), an improvement of SEK 2.2 million
(34%). Excluding foreign exchange effects and early deliveries in the second
quarter 2009, operating income rose by 13% 1) 2).
Profit before tax was SEK 12.9 million (11.3), an increase of SEK 1.6 million
(14%).
Profit after tax was SEK 8.0 million (7.7), an improvement of SEK 0.3 million
(4%).
?Key events in the third quarter of 2010
Study showing that Lactobacillus reuteri Protectis is effective in infants with
chronic constipation published in Journal of Pediatrics.
Collaboration agreement with SCA regarding intimate hygiene products and
products for the elderly.
"..Nestlé has started its launch in 19 countries and took sizeable deliveries of
cultures for infant formula with Reuteri. Nestlé is thus on its way to becoming
one of our largest customers. In other respects we have seen a continuation of
the trend noted earlier in the year, namely that sales of probiotic drops and
tablets in Europe are very strong, whereas sales in Japan have not yet gained
momentum after the change in our business model there" says Peter Rothschild,
President of BioGaia.
1) Most of the company's sales are denominated in foreign currency, primarily
EUR. With unchanged exchange rates, net sales would have been SEK 15.5 million
higher and operating profit would have been SEK 10.5 million higher for the
nine-month period.
2) In June 2009, deliveries worth the equivalent of SEK 5.4 million were moved
forward from the third to the second quarter, which meant that net sales and
profit for the third quarter of last year were lower than normal.
[HUG#1455712]
Interim report q3 2010 (pdf):
http://hugin.info/86913/R/1455712/395605.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioGaia AB via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 27.10.2010 - 07:59 Uhr
Sprache: Deutsch
News-ID 46331
Anzahl Zeichen: 0
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 171 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Interim report 1 January - 30 September 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
BioGaia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
